Mount Sinai School of Medicine, now known as the Icahn School of Medicine at Mount Sinai, is a prestigious medical school located in Manhattan, New York City. Founded in 1963, it is part of the Mount Sinai Health System, one of the largest healthcare systems in New York. The school is recognized for its innovative curriculum, cutting-edge research, and a strong emphasis on translational medicine, which seeks to apply findings from laboratory research to clinical settings quickly and effectively. Icahn School of Medicine offers a variety of degree programs, including MD, PhD, and dual degree options, and is known for its progressive approach to medical education, promoting a broader understanding of the social, economic, and cultural factors that affect patient care. The school is also renowned for its research in genetics, genomics, and biomedical informatics among other fields, making significant contributions to global health and clinical practice.
Innovative research from Mount Sinai has also identified new pathways for research. Researchers at the Icahn School of Medicine at Mount Sinai have achieved a…
Researchers have discovered a neurodevelopmental disorder linked to mutations in the RNU4-2 gene, a non-coding gene, which could impact tens of thousands globally. This finding…
Researchers at the Icahn School of Medicine at Mount Sinai have revealed intricate details on how some psychedelic drugs interact with serotonin receptors, triggering potential…
High-risk heart patients show improved outcomes and reduced bleeding by over 50% when aspirin is withdrawn one month after PCI, with ticagrelor treatment alone, according…
Researchers unveil how the self-killing activity of bacteria can be harnessed in the fight against antibiotic resistance. Scientists at the Icahn School of Medicine at…
Study sheds light on TAAR1, pointing to potential enhancement opportunities in drug development. Researchers at the Icahn School of Medicine at Mount Sinai have uncovered…
Genomic ‘Tweezer’ Ushers In a New Era of Precision in Microbiome Research Innovative method holds the potential to reshape our understanding of bacteria’s role in…
Statistical technique enhances genetic disease prediction in non-European populations, addressing healthcare equity. A team of scientists from Icahn School of Medicine at Mount Sinai has…
A Mount Sinai study found that blocking an allergy pathway boosts antitumor immunity in lung cancer, with an allergy drug, dupilumab, enhancing the effectiveness of…
A study reveals that PTSD affects how the brain processes traumatic memories differently from sad memories, offering insights for targeted treatments. A new analysis of…
Researchers have revealed how the protein TIMP2 regulates brain plasticity, particularly in the hippocampus, offering new insights into treating age-related disorders like Alzheimer’s by targeting…
Harnessing the power of explainable AI, researchers have unveiled the first insights into the complex workings of deep-brain stimulation therapy for treatment-resistant depression. A team…
New research highlights the constraints of commercial fitness equipment, underscoring the importance of a more personalized approach to exercise. Researchers from the Icahn School of…
A recent study from the Icahn School of Medicine at Mount Sinai suggests that fasting could negatively affect immune cells, potentially increasing the risk of…
Dr. Eimear Kenny, a renowned professor of Medicine, Genetics, and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, has made substantial contributions…
Mount Sinai’s AI model, HeartBEiT, improves the accuracy and detail of ECG diagnoses, even for rare conditions with limited data. It interprets ECGs as language…
Wearable devices may be a means to monitor psychological states through effortless data collection using artificial intelligence. Researchers at Mount Sinai have shown that data…
The largest study of its kind also demonstrated that the risk is shared across ethnicities. A multi-center study, led by the Icahn School of Medicine…